Join Dr. Suzie Bash and Kyle Frye as they explore the clinical value of NeuroQuant MS, a groundbreaking tool that enhances the management of multiple sclerosis (MS). This session discusses the feedback from referring neurologists, how NeuroQuant MS saves neuroradiologists valuable time, and the future of QMRI tools in MS care. Will tools like NeuroQuant MS become standard for the longitudinal evaluation of MS patients? Find out in this in-depth discussion.